CD8A and cancer: Confirming immune modulatory ARPs in CAFs and cancer cells (Fig. 3b), type 2 interferon (IFN-γ) signaling from CD8+ T cells to iCAFs, myCAFs, and cancer basal cells was exclusive to the older cohort (Fig. 5b, Supplementary Fig. 8f).